Technical Bulletins
About
The following technical bulletins are memos distributed to the UR Medicine Labs partners and affiliates. They are distributed via email and posted here for reference.
2024 Bulletins
- Lipid Panel LDL Cholesterol Calculation Update Memo
- TIBC/Transferrin Saturation Memo
- Strong West Urine Microscopic: New Orderable Test
- Herpes Simplex Virus (HSV) Type 1&2 IgM: Test Discontinued
- Confirmation Barbiturates: Change in Testing Laboratory/Reportable Range
- Myeloid NGS Panel Change in Assay Platform
- Bone Marrow Engraftment Monitoring Chimerism Assay Kit Change
- CJD/Prion Markers: Delay in Testing for total Tau Protein Memo
- HLACD Risk Assessment Update Memo
- ImmunoCAP Allergy: New In-house Tree Nut Component Testing Memo
- New Lung Cancer Molecular Panel Memo
- HHV-6A/B Quantitative NAAT, Plasma: New test
- CBC/D Modernization and Simplification Memo
- MMRV Memo
- Heme Malignancy (NGSH) Panl Re-activated in eRecord
- Plasma Metanephrines: Increased Stability Time and Room Temperature Shipping
- Celiac EBV Serology Memo
- UNGAL Testing in Urine: New In House Test
2023 Bulletins
- Hemolysis Interference Update Memo
- Pediatric GFR Equation Update Memo
- Updated Names for Testosterone Orders
- Molecular Test Reporting Changes
- Discontinuation of Caffeine Testing Memo
- HIV-1/2 Qualitative NAAT Memo
- Fondaparinux (Aristra) Anti-Xa-Cessation of Testing Memo
- DD Stability Increase Memo
- Change in ordering EGFR, KRAS and NRAS
- Collection and Transport of Urine for Culture and Urinalysis
- CEBPA Memo
- Celiac tTG DGP Memo
- CBCD Reference Ranges Memo
- Changes to Flow Cytometry
- TSH Reflex to Free T4 Memo
- DAU Memo
- Microarray Memo
- RHIO Downtime Notification
- ImmunoCAP Allergy: Peanut Components Memo
- Change in Folate Testing Lab
- Alcohol Panel Update
- Buprenorphine Change in Testing Lab
- Hemolysis Interference Update
2022 Bulletins
- Total/Free and Total Testosterone Orders Updated Options Memo
- Reticulocyte Count Update Memo
- Solid Tumor Next Generation Sequencing Delays
- Factor X Chromogenic Testing Discontinuation Memo
- Interferon Gamma Release Assay: Rebuilt
- Molecular Delays Memo
- Blood Bank Testing-Updated Specimen Tube Type (Revised)
- Apixaban Memo
- Tacrolimus and Cyclosporine Memo
- Pathology Delays
- BK Virus Quantitative NAAT Change to Assay
- Blood Lead Capillary and Venous Memo
- Blood Bank Testing-Updated Tube Type
- Adenovirus Quantitative NAAT New Test Memo
- UCDS Memo
- Lyme Testing Guidance for Healthcare Providers
- Anti-HBclgM Memo
- ImmunoCAP Interpretation Memo
- eGFR Updated Calculation Memo
- hsTnT Memo
- HPV Memo
2021 Bulletins
- Post-Vasectomy Semen Analysis: SMH ONLY
- Change to C. difficile Testing Algorithm
- Maternal Screen Testing: Change in Testing Laboratory
- Rheumatoid Factor with Reflex to Titer: Change to Assay
- Streptolysin O Antibody (ASO) Return to In House Testing
- Epstein-Barr Virus (EBV) Quantitative PCR, Plasma New Assay
- BCR-ABL1 Major Quantitavie Testing
- APIA PPIA Testing Now Available
- Meningitis Encephalitis PCR Panel: Temporarily Limited Panel
- BCR-ABL1 Quantitative Testing
- Cystatin C: New Test In-House
- Streptolysin O Antibody (ASO) Temporary Change to Turn-around Time
- Microarray 044k Discontinued Test
- PathDelays
- QuantiFERON TB Analyzer: Delay in Testing
- SARS-CoV-2 Antibody (IgG), Spike Protein
- Urine ETG: Change in Performing Laboratory
- Critical Shortage of Blue-Top Blood Collection Tubes-Suspension of Testing
- Immunotyping: Addition of Testing Platform
- Citrate Tube Critical Shortage Notification
- Critical Glucose Update for Newborns
- Positive Bias for Creatinine Results
- C-Reactive Protein (CRP): New Reference Range
- Random High Sensitivity Troponin: Expansion of Testing
- Euglobulin Clot Lysis Time: Cessation of Testing
- Homocysteine: Change in Specimen Requirements
- Aspirin Platelet Inhibition - Collection Tube Shortage
- QuantiFERON TB Analyzer: Delay in Testing
- Meningitis Encephalitis PCR Panel: Resume In-House Testing
- CMV Virus Testing for Neonatal Samples: Return to on-site testing
- Urine Ethyl Glucuronide: Change in Performing Laboratory
- Molecular Diagnostics Testing: Change in Performing Laboratory
2020 Bulletins
Microsatellite Instability (MSI): New Molecular Diagnostics Test
Urine Drug Confirmation Testing: Change in Performing Laboratory
2019 Novel Coronavirus: Guidelines for Patients Under Investigation
2019 Bulletins
Mycoplasma genitalium NAAT on genitourinary specimens: New Assay
Saliva Cortisol Testing: Temporary Change in Performing Laboratory
Urine Drug Confirmation Testing: Temporary Change in Performing Laboratory
Chlamydia (PDC) and Gonorrhoeae (PDG) Testing: Change to Assay
Maternal Screen Testing: Temporary Change in Testing Laboratory
Complete (comprehensive) Semen Analysis Panel: Change to Testing
Required regulatory information: Immunophenotyping by Flow Cytometry
Urinalysis reflex testing (UAR and UARWC): New Reflex Criteria
Magnesium (Mg) and Creatine Kinase (CK): Change in Reporting
2018 Bulletins
Anti-Cardiolipin (aCL) IgG/IgM and Beta-2 Glycoprotein I (aB2GPI) IgG/IgM: Change to Assay
QuantiFERON® TB (M.Tuberculosis exposure): Change in Testing
- Thyroglobulin and Related Antibodies: Notification of Assay Changes
- Anti-Cyclic Citrillinated Peptide (CCP) IgG: Change to Assay
- Chlamydia, Gonorrhoeae, and Trichomonas Test Delays
- ROMA (Risk of Ovarian Malignancy Algorithm)
- New High Sensitivity (HS) Troponin Assay
- Thromboelastography Testing (TEG): Critical Values
- BD Affirm Collection and Transport System for Triple Screen
- HSV-1 and HSV-2 Type Specific IgG Antibodies: Change to Assay
- Hemoglobin Electrophoresis Consent